What We Know About Immunity

The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract th ...  Show more

Earlier this year, school gates around the world slammed shut. The drastic measure worked in many places. Now, as fall approaches, attention is turning back to a pillar of a pandemic-resilient society: schools. The role of children in driving transmission of the coronavirus isn’t ...  Show more

Research from New York examining the blood of people who have recovered from Covid – 19 shows the majority have produced antibodies against the disease, The researchers hope to soon be able to establish whether this confers long term immunity as with more common viral infections. ...  Show more

Throughout the pandemic there’s been a big question: Will recovering from the virus or being treated by an effective vaccine provide lasting immunity? CNN Contributor Erin Bromage shares why new studies from the last few weeks make him more hopeful than ever that the answer could ...  Show more

Immunity to Covid-19. We've all been hoping to develop it ever since the virus emerged two years ago. Since then, a race to vaccinate the world has begun in earnest, with many countries rolling out booster shots in response to the rise of the Omicron variant. Health officials and ...  Show more

The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity, Anti-SARS-CoV-2 Monoclonal Antibodies for Preexposure COVID-19 Prophylaxis, Trials Test Mushrooms and Herbs as Anti–COVID-19 Agents. Related Article(s): The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity ...  Show more